Reconnecting

The current page stays visible while onset.to reconnects in the background.

Connection error

onset.to could not restore the live connection within 5 seconds. Reload the page to recover.

Log in

Psilocybin

Psilocybin content spanning clinical trials, mushroom science, public policy, and community discussion around one of the core substances in the psychedelic resurgence.

Most recent Latest added

Most recent Latest added

1,568 entries

January 3, 2027

UK petition calls for a legal review of psilocybin access and policy, asking Parliament to consider reform for medical use, research, and reduced criminal penalties

petition.parliament.uk · Jan 3, 2027

Psilocybin Mainstream Policy Research

Yesterday October 30, 2026

Roger Liggenstorfer über Drogenverbote, Zensur, frühe Pilzrituale und die psychedelische Geschichte im NEW ELEUSIS Podcast

lucys-magazin.com · Oct 30, 2026 · Roger Liggenstorfer

LSD Psilocybin Podcast HarmReduction +2 DE

October 29, 2026

Neuerscheinung rekonstruiert das Harvard-Psilocybin-Projekt und seine Konflikte um frühe psychedelische Forschung

lucys-magazin.com · Oct 29, 2026

Psilocybin Article Culture History Research DE

UC San Diego study links movement-triggered chronic back pain to the brain's sense of self and explores mindfulness and psilocybin

sciencedaily.com · Oct 29, 2026 · Fadel Zeidan

Psilocybin Article Clinical Consciousness Research

October 28, 2026

LSD and psilocybin produce opposite changes in cerebral blood flow and functional connectivity, study suggests

medicalxpress.com · Oct 28, 2026 · Ingrid Fadelli

LSD Psilocybin Article Clinical +2

Psilocybin: Neuroplastische Effekte hängen von bestimmten 5-HT2A-Rezeptoren ab, unabhängig von halluzinogenähnlichem Verhalten

psychedelia-stiftung.de · Oct 28, 2026

Psilocybin Article Consciousness Research DE

October 27, 2026

Weekly Psychedelic Policy Briefing: VA prepares ten treatment sites, DEA reviews five tryptamines, and cannabis hearing stays paused

psychedelicstoday.com · Oct 27, 2026 · Jack Gorsline

Psilocybin Ibogaine Article Clinical +2

Psilocybin vertont: B. Ashra veröffentlicht eine Klangkomposition nach Berechnungen von Hans Cousto

psychedelia-stiftung.de · Oct 27, 2026

Psilocybin Article Art Consciousness Music DE

Why pharmaceutical companies are investing billions in psychedelic drugs despite regulatory setbacks and unresolved safety questions

nature.com · Oct 27, 2026 · Lynne Peeples

Psilocybin MDMA Article Business +2

Why pharmaceutical companies continue investing billions in psychedelic drugs despite regulatory setbacks and unresolved safety questions

nature.com · Oct 27, 2026 · Lynne Peeples

Psilocybin MDMA Article Business +2

October 25, 2026

After a long, strange trip, Compass Pathways CEO Kabir Nath is close to bringing its psilocybin pill COMP360 to market

businessinsider.com · Oct 25, 2026

Psilocybin Article Business Clinical Industry

Psilocybin's controlled evidence for alcohol use disorder ends at week 36, while an uncontrolled repeat-dose follow-up found only brief reductions

behavioralwire.com · Oct 25, 2026 · Editorial Desk

Psilocybin Article Clinical Research Safety

October 23, 2026

Before European Approvals: Norway, Germany, Switzerland, the UK and Estonia Build Psychedelic Access Pathways at TAIP 2026

psychedelicalpha.com · Oct 23, 2026 · Ryan Khan

Psilocybin Ketamine Article Clinical +2

FDA approval of psychedelics could drive an underground boom, requiring public health measures for risks and adverse events

ecstaticintegration.org · Oct 23, 2026 · Jules Evans

Psilocybin MDMA Article HarmReduction +2

October 22, 2026

Timothy Leary Did Not Cause the Drug War: Why Prohibition, Racism, Politics, and Research Barriers Matter More

psychedelicstoday.com · Oct 22, 2026 · Joe Moore

LSD Psilocybin Article History +2

Timothy Leary Did Not Cause the Drug War: Reconsidering Prohibition, Lost Research, and the Politics of Psychedelic Respectability

psychedelicstoday.com · Oct 22, 2026 · Joe Moore

LSD Psilocybin Essay Ethics +2

October 21, 2026

New human data suggests psilocybin may reduce inflammation and mitochondrial stress in Parkinson's disease

npr.org · Oct 21, 2026 · Will Stone

Psilocybin Article Clinical Research Safety

Poacher Turned Gamekeeper: HHS’ Matt Zorn on Ibogaine, Right to Try and the Psychedelics Executive Order

psychedelicalpha.com · Oct 21, 2026 · Josh Hardman

Psilocybin Ibogaine Article Industry +2

Psychedelic Harvard: Warum die Harvard University als Geburtsort der US-amerikanischen Psychedelik gilt

lucys-magazin.com · Oct 21, 2026

Psilocybin Article Culture History Research DE

Jordan Kronick on Peaking, filming psychedelic healing, Ecstasy Rising, brain injury in sports, and drug policy

psychedelicstoday.com · Oct 21, 2026 · Psychedelics Today

Psilocybin MDMA Podcast Culture +2

ICER to assess synthetic psilocybin therapy COMP360 for treatment-resistant depression, with public comments open through November 10, 2026

icer.org · Oct 21, 2026

Psilocybin Article Clinical Policy Research

ICER assessment of treatment-resistant depression and synthetic psilocybin from COMPASS Pathways

icer.org · Oct 21, 2026

Psilocybin Article Clinical Research

October 20, 2026

Psilocybin PTSD evidence appeared first in an SEC filing, exposing how media, journals and registries show different levels of trial maturity

behavioralwire.com · Oct 20, 2026 · Editorial Desk

Psilocybin Article Clinical Mainstream Research

What Psychedelics Have Taught Me About Paying Attention, Emotional Regulation, and Presence as a Father

psychedelicstoday.com · Oct 20, 2026 · Kevin Cranford

Psilocybin Essay Integration Society Therapy

Podcast: Early Healthcare Forum Takeaways, FDA’s Ibogaine Blueprint, and Compass Talks Pricing

psychedelicalpha.com · Oct 20, 2026 · Josh Hardman

Psilocybin Ibogaine Podcast Clinical +2